title: Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs.
authors.forename: Koenraad
authors.initials: K
authors.lastname: Blot
authors.forename: Martin C
authors.initials: MC
authors.lastname: Michel
mesh_terms: D000631:Aminopyridines / Q000009:adverse effects*; D000700:Analgesics / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008297:Male; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D000631:Aminopyridines; D000700:Analgesics